Sally Elfishawi

Sally Elfishawi

National Cancer Institute, Egypt - Cairo / Egypt
Medical and Health Sciences / Clinical Pathology
AD Scientific Index ID: 4814747
المعهد القومى للاورام بمصر
person_outline Sally Elfishawi's MOST POPULAR ARTICLES
1-) Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop MK Misra, DG Augusto, GM Martin, N Nemat-Gorgani, J Sauter, ... Human immunology 79 (12), 825-833, 2018 162018
2-) HLA Class I in Egyptian patients with Behçet’s disease: new association with susceptibility, protection, presentation and severity of manifestations MM Elfishawi, F Elgengehy, G Mossallam, S Elfishawi, M Alfishawy, ... Immunological investigations 48 (2), 121-129, 2019 142019
3-) Acute lymphoblastic leukemia–like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patientsEO Rasekh, R Osman, D Ibraheem, Y Madney, E Radwan, A Gameel, ...Annals of Hematology 100, 699-707, 202182021
4-) Behcet disease, new insights in disease associations and manifestations: a next-generation sequencing studyM Elfishawi, G Mossallam, DG Augusto, G Montero-Martin, H de Bruin, ...Clinical & Experimental Immunology 204 (1), 144-151, 2021112021
5-) The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched siblingSM Elfishawi, GI Mossallam, R Abd El-Fattah, A El-Haddad, AM KamelHuman immunology 78 (11-12), 684-691, 201782017